Reducing the incidence of postoperative nausea and vomiting.
In the first part of this article (Vol 53(7) 1995, p.327), the physiology of vomiting and the factors known to influence postoperative nausea and vomiting (PONV) were summarised. In this second part the therapeutic options available to reduce the incidence of PONV are reviewed.
Broomhead
C J
CJ
Department of Anaesthesia, Harefield Hospital, Middlesex.
D000768:Anesthesia, General / Q000009:adverse effects*; D001285:Atropine / Q000008:administration & dosage / Q000627:therapeutic use*; D013502:General Surgery; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D008787:Metoclopramide / Q000008:administration & dosage / Q000627:therapeutic use*; D009325:Nausea / Q000188:drug therapy* / Q000209:etiology*; D011184:Postoperative Period; D011346:Prochlorperazine / Q000008:administration & dosage / Q000627:therapeutic use*; D012601:Scopolamine / Q000008:administration & dosage / Q000627:therapeutic use*; D012702:Serotonin Antagonists / Q000627:therapeutic use; D014839:Vomiting / Q000188:drug therapy* / Q000209:etiology*
D006634:Histamine H1 Antagonists; D012702:Serotonin Antagonists; D001285:Atropine; D012601:Scopolamine; D008787:Metoclopramide; D011346:Prochlorperazine